Baidu
map

2022 ESMO/EHA跨学科专家共识:COVID-19流行期间血液肿瘤患者的管理

2022-01-28 欧洲肿瘤内科学会 ESMO Open

2022年1月,欧洲肿瘤内科学会(ESMO)联合欧洲血液学协会(EHA)共同发布了COVID-19流行期间血液肿瘤患者的管理共识。COVID-19的流行,给血液系统恶性肿瘤患者的管理带来了巨大挑战,本

中文标题:

2022 ESMO/EHA跨学科专家共识:COVID-19流行期间血液肿瘤患者的管理

英文标题:

Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert Consensus

发布机构:

欧洲肿瘤内科学会

发布日期:

2022-01-28

简要介绍:

2022年1月,欧洲肿瘤内科学会(ESMO)联合欧洲血液学协会(EHA)共同发布了COVID-19流行期间血液肿瘤患者的管理共识。COVID-19的流行,给血液系统恶性肿瘤患者的管理带来了巨大挑战,本文主要针对COVID-19流行期间血液肿瘤患者的管理提供共识声明。

相关资料下载:
[AttachmentFileName(sort=1, fileName=2022 ESMO_EHA跨学科专家共识:COVID-19流行期间血液肿瘤患者的管理.pdf)] GetToolGuiderByIdResponse(projectId=1, id=3fa0b1c0023808f7, title=2022 ESMO/EHA跨学科专家共识:COVID-19流行期间血液肿瘤患者的管理, enTitle=Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert Consensus, guiderFrom=ESMO Open, authorId=0, author=, summary=2022年1月,欧洲肿瘤内科学会(ESMO)联合欧洲血液学协会(EHA)共同发布了COVID-19流行期间血液肿瘤患者的管理共识。COVID-19的流行,给血液系统恶性肿瘤患者的管理带来了巨大挑战,本, cover=https://img.medsci.cn/2022315/1647329044883_1608702.jpg, journalId=0, articlesId=null, associationId=14, associationName=欧洲肿瘤内科学会, associationIntro=欧洲肿瘤内科学会(ESMO,European Society for Medical Oncology )是1975年成立的非盈利组织,是欧洲领先的专业组织,致力于提高肿瘤内科的专业性,推进癌症治疗和护理的多学科诊疗方法。, copyright=0, guiderPublishedTime=Fri Jan 28 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">2022年1月,欧洲肿瘤内科学会(ESMO)联合欧洲血液学协会(EHA)共同发布了COVID-19流行期间血液肿瘤患者的管理共识。COVID-19的流行,给血液系统恶性肿瘤患者的管理带来了巨大挑战,本文主要针对COVID-19流行期间血液肿瘤患者的管理提供共识声明。</span></p>, tagList=[TagDto(tagId=3203, tagName=血液肿瘤)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤, tenant=100), CategoryDto(categoryId=21, categoryName=血液科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5625, appHits=58, showAppHits=0, pcHits=190, showPcHits=5567, likes=1, shares=21, comments=2, approvalStatus=1, publishedTime=Wed Mar 16 15:22:00 CST 2022, publishedTimeString=2022-01-28, pcVisible=1, appVisible=1, editorId=0, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=dajiong, createdTime=Tue Mar 15 15:24:35 CST 2022, updatedBy=1608702, updatedName=dajiong, updatedTime=Fri Jan 05 17:57:47 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2022 ESMO_EHA跨学科专家共识:COVID-19流行期间血液肿瘤患者的管理.pdf)])
2022 ESMO_EHA跨学科专家共识:COVID-19流行期间血液肿瘤患者的管理.pdf
下载请点击:
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1229734, encodeId=e1c61229e34ee, content=<a href='/topic/show?id=66c489335e5' target=_blank style='color:#2F92EE;'>#血液肿瘤#</a><a href='/topic/show?id=f52851329b' target=_blank style='color:#2F92EE;'>#Covid-19#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89335, encryptionId=66c489335e5, topicName=血液肿瘤), TopicDto(id=5132, encryptionId=f52851329b, topicName=Covid-19)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Thu Jun 30 14:49:15 CST 2022, time=2022-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203217, encodeId=eb57120321ef8, content=😃, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160727/IMG5797E92F3059A9439.jpg, createdBy=bd6f1928886, createdName=bettermecx, createdTime=Wed Mar 16 19:51:54 CST 2022, time=2022-03-16, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1229734, encodeId=e1c61229e34ee, content=<a href='/topic/show?id=66c489335e5' target=_blank style='color:#2F92EE;'>#血液肿瘤#</a><a href='/topic/show?id=f52851329b' target=_blank style='color:#2F92EE;'>#Covid-19#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89335, encryptionId=66c489335e5, topicName=血液肿瘤), TopicDto(id=5132, encryptionId=f52851329b, topicName=Covid-19)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Thu Jun 30 14:49:15 CST 2022, time=2022-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203217, encodeId=eb57120321ef8, content=😃, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160727/IMG5797E92F3059A9439.jpg, createdBy=bd6f1928886, createdName=bettermecx, createdTime=Wed Mar 16 19:51:54 CST 2022, time=2022-03-16, status=1, ipAttribution=)]
    2022-03-16 bettermecx

    😃

    0

Baidu
map
Baidu
map
Baidu
map